Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfusion by Arterial Spin Labelling following Single-dose Tadalafil in Small Vessel Disease
2015-001235-20Phase 2Completed
- Sponsor
- St George's, University of London
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tadalafil in Cerebral Small Vessel Disease (CSVD), sponsored by St George's, University of London. Primary endpoint: Primary: Change in local cerebral blood flow in deep brain nuclei and deep white matter. Started May 2015; status: completed.
02
Drugs
tadalafil
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on 2015-001235-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001235-20.